Found 14 matching trials
Thorough QT (TQT) Study of TD-4208 in Healthy Subjects PHASE1 The purpose of this study is to evaluate if TD-4208, an investigational dru...
Show More Learn More & Join Trial
Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD) PHASE3 This study is a phase III clinical study to assess the efficacy and safety ...
Show More Location
Anhui Medical University - Hefei First People's Hospital
Learn More & Join Trial
A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) PHASE2 This study evaluated the safety and efficacy of four doses of TD-4208 and a...
Show More Location
Upstate Pharmaceutical Research
Learn More & Join Trial
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD) PHASE4 The primary aim is to determine whether nebulized Formoterol twice daily pl...
Show More Location
University of Tennessee Medical Center
Learn More & Join Trial
A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD PHASE3 The primary objective of the study was to characterize the safety and toler...
Show More Location
Theravance Biopharma Investigational Site
Learn More & Join Trial
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 The purpose of this study is to measure the safety and tolerability of TD 4...
Show More Location
Palmetto Medical Research Associates L.L.C
Learn More & Join Trial
A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) PHASE2 This study evaluated the safety and efficacy of once and twice daily TD-420...
Show More Location
American Health Research
Learn More & Join Trial
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) PHASE3 The purpose of this study is to measure the effectiveness and safety of TD ...
Show More Location
Palmetto Medical Research Associates L.L.C.
Learn More & Join Trial
7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease PHASE2 This study will characterize the dose response of TD-4208 after 7 days of d...
Show More Learn More & Join Trial
Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD PHASE3 This study is a randomized, double-blind, double-dummy, parallel group stud...
Show More Location
Clinical Research of Rock Hill
Learn More & Join Trial